| 000 | 01711 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517055757.0 | ||
| 264 | 0 | _c20160826 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1461-7285 | ||
| 024 | 7 |
_a10.1177/0269881115609015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSun, Hong | |
| 245 | 0 | 0 |
_aPsychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects. _h[electronic resource] |
| 260 |
_bJournal of psychopharmacology (Oxford, England) _cNov 2015 |
||
| 300 |
_a1159-69 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAzepines _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEthanol _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrexin Receptor Antagonists _xadverse effects |
| 650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
| 650 | 0 | 4 |
_aReaction Time _xdrug effects |
| 650 | 0 | 4 |
_aTriazoles _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aYee, Ka Lai | |
| 700 | 1 | _aGill, Sean | |
| 700 | 1 | _aLiu, Wen | |
| 700 | 1 | _aLi, Xiaodong | |
| 700 | 1 | _aPanebianco, Deborah | |
| 700 | 1 | _aMangin, Eric | |
| 700 | 1 | _aMorrison, Dennis | |
| 700 | 1 | _aMcCrea, Jacqueline | |
| 700 | 1 | _aWagner, John A | |
| 700 | 1 | _aTroyer, Matthew D | |
| 773 | 0 |
_tJournal of psychopharmacology (Oxford, England) _gvol. 29 _gno. 11 _gp. 1159-69 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0269881115609015 _zAvailable from publisher's website |
| 999 |
_c25351649 _d25351649 |
||